| Trial ID: | L3185 |
| Source ID: | NCT01497574
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: insulin detemir|DRUG: insulin glargine
|
| Outcome Measures: |
Primary: Area under the insulin concentration curve (AUC) | Secondary: Maximum insulin concentration (Cmax)|Time to maximum insulin concentration (tmax)|Adverse events
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
PHASE1
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-05
|
| Completion Date: |
2005-10
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-30
|
| Locations: |
Novo Nordisk Investigational Site, Hannover, 30173, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01497574
|
